Agreement combines Gadeta’s gamma delta target and TCR identification expertise with Immunocore’s TCR bispecific engineering, development and commercialization capabilities to develop gamma delta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback